Regenxbio RGNX EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Regenxbio’s reported figures.
Plus components not separately reported this period.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's EBIT?
- Regenxbio (RGNX) reported EBIT of -$83.36M in Q1 2026.
- How has Regenxbio's EBIT changed year-over-year?
- Regenxbio's EBIT decreased by 787.4% year-over-year, from $12.13M to -$83.36M.
- What is the long-term trend for Regenxbio's EBIT?
- Over 4 years (2021 to 2025), Regenxbio's EBIT has grown at a 0.2% compound annual growth rate (CAGR), from $159.98M to -$161.2M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.